Kits for modulation of anti-rejection therapies and early detection of neurodegenerative diseases

The invention consists of a nanofunctionalized device that enables the quantitative determination of a specific biomarker, the FKBP12 protein, involved in many diseases.

Settore:

Life sciences

Research Institution:

Università degli Studi di Firenze

Publication number:

WO2021124269A1

TRL:

4

Technologies, Systems, Applications:

Biotechnologies

Technological Priority:

Biotechnologies for health,
Biomedical, pharmaceutical, pharmacological technologies